Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization study
Milde tot matige gastro-intestinale bijwerkingen, waaronder misselijkheid, diarree, braken en constipatie, werden gemeld bij 67 (35%) van de 190 deelnemers in de retatrutide-groepen en 16 (35%) van de 46 deelnemers in de 1,5 mg dulaglutide-groep
This involved 40 patients
Mean HbA1c reductions were significantly greater with tirzepatide vs semaglutide (estimated treatment difference [95% confidence interval] 0.12% [0.18, 0.06]
While skin irritation is not listed as a primary side effect in most clinical trials, patient reports and dermatological literature suggest a subset of users experience increased skin reactivity, dryness, or localized inflammation
Environmental factors, stress, and aging also contribute to its decline